603 related articles for article (PubMed ID: 31708118)
1. TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands.
van der Meij KRM; Sistermans EA; Macville MVE; Stevens SJC; Bax CJ; Bekker MN; Bilardo CM; Boon EMJ; Boter M; Diderich KEM; de Die-Smulders CEM; Duin LK; Faas BHW; Feenstra I; Haak MC; Hoffer MJV; den Hollander NS; Hollink IHIM; Jehee FS; Knapen MFCM; Kooper AJA; van Langen IM; Lichtenbelt KD; Linskens IH; van Maarle MC; Oepkes D; Pieters MJ; Schuring-Blom GH; Sikkel E; Sikkema-Raddatz B; Smeets DFCM; Srebniak MI; Suijkerbuijk RF; Tan-Sindhunata GM; van der Ven AJEM; van Zelderen-Bhola SL; Henneman L; Galjaard RH; Van Opstal D; Weiss MM;
Am J Hum Genet; 2019 Dec; 105(6):1091-1101. PubMed ID: 31708118
[TBL] [Abstract][Full Text] [Related]
2. Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.
Liu Y; Liu H; He Y; Xu W; Ma Q; He Y; Lei W; Chen G; He Z; Huang J; Liu J; Liu Y; Huang Q; Yu F
Hum Genomics; 2020 Jun; 14(1):21. PubMed ID: 32503639
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2019; 19(4):1-166. PubMed ID: 30847010
[TBL] [Abstract][Full Text] [Related]
4. Cell-free DNA screening for aneuploidies in 7113 pregnancies: single Italian centre study.
Mesoraca A; Margiotti K; Dello Russo C; Cesta A; Cima A; Longo SA; Barone MA; Viola A; Sparacino D; Giorlandino C
Genet Res (Camb); 2020 Jun; 102():e5. PubMed ID: 32539871
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Z-score accuracy of noninvasive prenatal testing for fetal trisomies 13, 18 and 21 at a single center.
Junhui W; Ru L; Qiuxia Y; Dan W; Xiuhong S; Yongling Z; Xiangyi J; Fatao L; Xuewei T; Guilan C; Fan J; Fucheng L; Fang F; Yan L; Lina Z; Cuixing Y; Jian L; Dongzhi L; Can L
Prenat Diagn; 2021 May; 41(6):690-696. PubMed ID: 33480032
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of five prenatal screening strategies for trisomies and other unbalanced chromosomal abnormalities: model-based analysis.
Le Bras A; Salomon LJ; Bussières L; Malan V; Elie C; Mahallati H; Ville Y; Vekemans M; Durand-Zaleski I
Ultrasound Obstet Gynecol; 2019 Nov; 54(5):596-603. PubMed ID: 31006923
[TBL] [Abstract][Full Text] [Related]
7. Clinical Validation of Non-Invasive Prenatal Testing for Fetal Common Aneuploidies in 1,055 Korean Pregnant Women: a Single Center Experience.
Lee DE; Kim H; Park J; Yun T; Park DY; Kim M; Ryu HM
J Korean Med Sci; 2019 Jun; 34(24):e172. PubMed ID: 31222985
[TBL] [Abstract][Full Text] [Related]
8. Cytogenomic results following high-chance non-invasive prenatal testing: a UK national audit.
Togneri FS; Allen SK; Mann K; Holgado E; Morgan S
Genet Res (Camb); 2020 Sep; 102():e7. PubMed ID: 32867862
[TBL] [Abstract][Full Text] [Related]
9. Routine first-trimester screening for fetal trisomies in twin pregnancy: cell-free DNA test contingent on results from combined test.
Galeva S; Konstantinidou L; Gil MM; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2019 Feb; 53(2):208-213. PubMed ID: 30353581
[TBL] [Abstract][Full Text] [Related]
10. Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test.
Gil MM; Revello R; Poon LC; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Jan; 47(1):45-52. PubMed ID: 26498918
[TBL] [Abstract][Full Text] [Related]
11. Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Part I-clinical impact.
Oepkes D; Page-Christiaens GC; Bax CJ; Bekker MN; Bilardo CM; Boon EM; Schuring-Blom GH; Coumans AB; Faas BH; Galjaard RH; Go AT; Henneman L; Macville MV; Pajkrt E; Suijkerbuijk RF; Huijsdens-van Amsterdam K; Van Opstal D; Verweij EJ; Weiss MM; Sistermans EA;
Prenat Diagn; 2016 Dec; 36(12):1083-1090. PubMed ID: 27750376
[TBL] [Abstract][Full Text] [Related]
12. Cost and efficacy comparison of prenatal recall and reflex DNA screening for trisomy 21, 18 and 13.
Bestwick JP; Wald NJ
PLoS One; 2019; 14(7):e0220053. PubMed ID: 31344071
[TBL] [Abstract][Full Text] [Related]
13. Prenatal reflex DNA screening for trisomy 21, 18 and 13.
Wald NJ
Expert Rev Mol Diagn; 2018 May; 18(5):399-401. PubMed ID: 29633889
[No Abstract] [Full Text] [Related]
14. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
[TBL] [Abstract][Full Text] [Related]
15. [Clinical application and evaluation of health economics for non-invasive prenatal testing of fetuses in Tianjin].
Ma R; Li X; Xu S; Shi Y; Ju D; Li Y; Meng F; Wang X; Du X; Xu N; Zhang Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Feb; 40(2):135-142. PubMed ID: 36709929
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
Lau TK; Cheung SW; Lo PS; Pursley AN; Chan MK; Jiang F; Zhang H; Wang W; Jong LF; Yuen OK; Chan HY; Chan WS; Choy KW
Ultrasound Obstet Gynecol; 2014 Mar; 43(3):254-64. PubMed ID: 24339153
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of non-invasive prenatal testing in preventing birth defects].
Zhang W; Li S; Tang P; Wang J; Gu S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Oct; 37(10):1061-1064. PubMed ID: 32924101
[TBL] [Abstract][Full Text] [Related]
18. Performance of cell-free DNA testing for common fetal trisomies in triplet pregnancies.
Zakaria H; Kleinfinger P; Lohmann L; Costa JM; Tsatsaris V; Salomon LJ; Jouannic JM; Rosenblatt J; Demain A; Benachi A; El Khattabi L; Vivanti AJ
Prenat Diagn; 2024 May; 44(5):555-561. PubMed ID: 38448008
[TBL] [Abstract][Full Text] [Related]
19. [Application of non-invasive prenatal testing for the screening of fetal chromosomal abnormalities in 12 085 cases].
Wang L; Zhou C; Hu Y; Jin Y; Liu X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Oct; 37(10):1069-1073. PubMed ID: 32924103
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study.
van Prooyen Schuurman L; Sistermans EA; Van Opstal D; Henneman L; Bekker MN; Bax CJ; Pieters MJ; Bouman K; de Munnik S; den Hollander NS; Diderich KEM; Faas BHW; Feenstra I; Go ATJI; Hoffer MJV; Joosten M; Komdeur FL; Lichtenbelt KD; Lombardi MP; Polak MG; Jehee FS; Schuring-Blom H; Stevens SJC; Srebniak MI; Suijkerbuijk RF; Tan-Sindhunata GM; van der Meij KRM; van Maarle MC; Vernimmen V; van Zelderen-Bhola SL; van Ravesteyn NT; Knapen MFCM; Macville MVE; Galjaard RH;
Am J Hum Genet; 2022 Jun; 109(6):1140-1152. PubMed ID: 35659929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
